(Q40319765)

19 September 2017

title

Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma (English)

1 reference

19 September 2017

12

1 reference

19 September 2017

Sensi M

1

1 reference

19 September 2017

Nicolini G

2

1 reference

19 September 2017

Petti C

3

1 reference

19 September 2017

Bersani I

4

1 reference

19 September 2017

Lozupone F

5

1 reference

19 September 2017

Molla A

6

1 reference

19 September 2017

Vegetti C

7

1 reference

19 September 2017

Nonaka D

8

1 reference

19 September 2017

Mortarini R

9

1 reference

19 September 2017

Parmiani G

10

1 reference

19 September 2017

Fais S

11

1 reference

19 September 2017

language of work or name

English

0 references

publication date

6 February 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

25

1 reference

19 September 2017

issue

24

1 reference

19 September 2017

page(s)

3357-3364

1 reference

Ras mutations in human melanoma: a marker of malignant progression

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Tumor-stroma interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

BRAF alterations are associated with complex mutational profiles in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Guilty as charged: B-RAF is a human oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

The role of B-RAF in melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Remodeling of the microenvironment by aggressive melanoma tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Therapeutic targeting of the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

BRAF kinase gene V599E mutation in growing melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

RAS oncogenes: the first 30 years.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

BRAFE600-associated senescence-like cell cycle arrest of human naevi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Microarray expression profiling in melanoma reveals a BRAF mutation signature.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

High frequency of BRAF mutations in nevi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Targeting the mitogen-activated protein kinase cascade to treat cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

The RAF proteins take centre stage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209379

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209379

1 reference

Dimensions Publication ID

19 September 2017

1014115295

0 references

1 reference